Treatment Information

Back

Ovarian Cancer treatment details. Chemotherapy.

University Hospital Leuven, Leuven, Belgium.

Survival: monthsCountry:Belgium
Toxiciy Grade:5City/State/Province:Leuven
Treatments:ChemotherapyHospital:University Hospital Leuven
Drugs:Journal:Link
Date:Nov 2013

Description:

Patients:
This phase 2 study involved 69 recurrent epithelial ovarian cancer patients with a median age of 61 years.

Treatment:
Patients received chemotherapy with etirinotecan pegol.

Toxicities:
There were two treatment-related deaths due to kidney failure and sepsis. Grade 3-4 dehydration, diarrhea, fatigue, and nausea were also reported.

Results:
The median overall survival was 11.1 months.

Support:
This study was supported by Nektar Therapeutics (makers of etirinotecan pegol).

Correspondence: Dr. Ignace Vergote; email: [email protected]



Back